Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMF-650 in Overweight or Obese Participants
NCT07223216Phase 1Completed
- Sponsor
- Biomea Fusion
- Start
- Oct 2025
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of BMF-650 in obesity, sponsored by Biomea Fusion. Started Oct 2025; status: completed.
02
Drugs
BMF-650
03
Conditions
obesity
Beyond the preview
Go deeper on NCT07223216.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07223216.